Jean Pierre Sommadossi Atea Pharmaceuticals, Inc. (AVIR) insider trading activity

Jean Pierre Sommadossi is President, CEO, and Chairman of Atea Pharmaceuticals, Inc.. Currently has a direct ownership of 300,940 shares of AVIR, which is worth approximately $878,744. The most recent transaction as insider was on Jan 31, 2025, when has been sold 88,601 shares (Common Stock) at a price of $3.06 per share, resulting in proceeds of $271,119. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 301K

158.19% 3M change

158.19% 12M change

Total Value Held $878,744

Jean-Pierre Sommadossi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 31 2025	SELL Payment of exercise price or tax liability	$271,119 $3.06 p/Share	88,601 Reduced 22.74%	300,940 Common Stock
Jan 31 2025	BUY Grant, award, or other acquisition	-	99,517 Added 20.35%	389,541 Common Stock
Jan 31 2025	BUY Exercise of conversion of derivative security	-	173,467 Added 37.43%	290,024 Common Stock
Feb 01 2024	SELL Open market or private sale	$219,103 $3.85 p/Share	56,910 Reduced 32.81%	116,557 Common Stock
Jan 31 2024	BUY Exercise of conversion of derivative security	-	173,467 Added 50.0%	173,467 Common Stock

Also insider at

KZR

Kezar Life Sciences, Inc. Healthcare

Director

ABGI

ABG Acquisition Corp. I Financial Services

Director